Related Experiment Video
Updated: Jul 16, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Identifying diabetic ketoacidosis encounters at diagnosis among children with type 1 diabetes in claims data
R Brett McQueen1, Nai-Chia Chen1, Eric J Gutierrez1
1University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045, USA.
Insights
Claims data identify many, but not all, diabetic ketoacidosis (DKA) cases in new type 1 diabetes patients. DKA significantly increases inpatient encounters but reduces emergency room visits.
Area of Science:
- Pediatric Endocrinology
- Health Informatics
- Diabetes Research
Background:
- Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes.
- Accurate identification of DKA cases is crucial for understanding disease burden and resource utilization.
- Claims data are increasingly used for health research but their performance in identifying specific conditions needs evaluation.
Purpose of the Study:
- To quantify the accuracy of claims data in identifying DKA cases among newly diagnosed type 1 diabetes patients.
- To estimate healthcare resource utilization in type 1 diabetes patients with and without DKA.
Main Methods:
- Matched individuals from a diabetes registry to an all-payer claims database.
- Evaluated DKA identification performance using type 1 diabetes and DKA codes in emergency department (ER) and inpatient (IP) settings.
- Estimated associations between laboratory-confirmed DKA and healthcare resource utilization (ER and IP encounters).
Main Results:
- A significant proportion (56%) of newly diagnosed type 1 diabetes patients experienced DKA.
- Strict claims coding definitions for DKA had lower sensitivity (63%) but higher specificity (76%) compared to looser definitions (sensitivity 89%, specificity 60%).
- Laboratory-confirmed DKA was associated with over 5 times the rate of inpatient encounters and fewer ER-only encounters.
Conclusions:
- Claims data may not capture all DKA encounters at the time of type 1 diabetes diagnosis.
- Further research is needed to refine coding and setting analyses for comprehensive DKA burden estimation.
Background:
Quantify the performance of claims data in identifying diabetic ketoacidosis (DKA) cases and estimate healthcare resource utilization among newly diagnosed type 1 diabetes patients with and without DKA.
Methods:
We matched individuals <18 years of age from the Barbara Davis Center for Diabetes Registry to the Colorado all-payer claims database to estimate variation in the performance of claims (ie, type 1 diabetes and DKA codes in emergency department [ER] and inpatient [IP] settings) in identifying DKA cases from 2014 to 2019. We estimated the unadjusted and adjusted associations of laboratory-confirmed DKA with resource utilization using encounters and incidence rate ratios with 95% confidence intervals.
Results:
After applying algorithms for identifying type 1 diabetes with continuous enrollment criteria, n = 728 (62% match of the sample) represented an insured population residing in Colorado. Mean age at onset was approximately 9.48 years, with a proportion of DKA events at diagnosis of 56%. Strict coding definitions of DKA (DKA and type 1 diabetes) had lower sensitivity (63%) and higher specificity (76%) than looser definitions (type 1 diabetes or DKA), which had higher sensitivity (89%) and lower specificity (60%). Laboratory-confirmed DKA was associated with over 5 times the rate of IP encounters compared with no confirmed DKA (incidence rate ratio [IRR], 5.49; 95% confidence interval, 4.03-7.47) but fewer ER-only encounters (IRR, 0.36; 95% confidence interval, 0.24-0.54).
Conclusion:
Claims data may not capture all DKA encounters at type 1 diabetes diagnosis. Future research should provide sensitivity analyses across coding and settings to estimate the burden of DKA.
Related Concept Videos
Diabetic Ketoacidosis l: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
